Botox Dosing for Platysmal Band Release
For mild to moderate platysmal bands, inject 15-20 units of onabotulinumtoxinA (Botox) per band, with a maximum total dose of 100 units, using a standardized injection technique that targets the medial border of each band at multiple points along its length. 1
Dose Recommendations by Severity
Mild to Moderate Bands (Type II-III)
- 15-20 units of onabotulinumtoxinA per band is the standard dose that achieves optimal efficacy with minimal complications 1
- Maximum total dose should not exceed 100 units across all bands 2
- This dosing achieved a 93.7% response rate at 2 weeks and 86% response rate at 3 months in systematic review data 1
Moderate to Severe Bands (Type III-IV)
- For abobotulinumtoxinA (Dysport), use 120-180 units total in a two-stage approach 3
- The higher 180-unit dose demonstrated superior grade improvement (≥2 grades) and longer duration of effect compared to 120 units 3
- Optional 90-unit touch-up can be performed if initial response is suboptimal 3
Injection Technique
The standardized approach involves:
- Inject along the medial border of each visible platysmal band 1
- Use multiple injection points spaced 1-2 cm apart along the length of each band 1
- Inject superficially into the platysma muscle itself, avoiding deeper structures 2
- For abobotulinumtoxinA, use the more concentrated on-label reconstitution (1.5 mL/300 units) to minimize volume and reduce diffusion risk 3
Critical Safety Considerations
Dysphagia risk exists even at conservative doses:
- Dysphagia has been reported with doses as low as 60 units of abobotulinumtoxinA (equivalent to 20 units onabotulinumtoxinA) 2
- The mechanism may involve diffusion to underlying deglutition muscles, larynx, or neck flexors 2
- Risk factors include injection technique errors, intravascular injection, or inadvertent deeper placement 2
Complication rates:
- Overall complication rate is 15.4%, with most being minor and self-limited 1
- Transient positional neck weakness can occur with higher doses but resolves spontaneously 3
- No cases of airway obstruction have been reported in aesthetic platysmal band treatment 4
Patient Selection Algorithm
Best candidates (Type II-III):
- Mild to moderate horizontal neck rhytids with thin to moderate platysma muscle bands 5
- Minimal to moderate skin laxity 5
- These patients achieve the highest satisfaction rates 5
Suboptimal candidates (Type IV):
- Severe skin laxity limits results regardless of muscle treatment 4, 5
- Botox does not provide any lifting effect of the lower face 4
- Surgical intervention should be considered for these patients 5